The influence of gender, weight, height and BMI on pentosidine concentrations in plasma of hemodialyzed patients

Journal of Nephrology

Volumn 19, Issue 1, 2006, Pages 65-69

  Slowik Zylka, Dorota ^a   Safranow, Krzysztof ^a   Dziedziejko, Violetta ^a   Dutkiewicz, Grazyna ^a   Ciechanowski, Kazimierz ^a   Chlubek, Dariusz ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

Body mass index; Carbonyl stress; Chronic hemodialysis; Dry weight; High performance liquid chromatography; Pentosidine

Indexed keywords

C REACTIVE PROTEIN; PENTOSIDINE; TRICHLOROACETIC ACID;

ADULT; ANTHROPOMETRY; ARTICLE; BODY MASS; CARBOHYDRATE ANALYSIS; CARBOHYDRATE METABOLISM; CATABOLISM; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CORRELATION ANALYSIS; DRY WEIGHT; FEMALE; HEIGHT; HEMODIALYSIS; HEMODIALYSIS PATIENT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYDROLYSIS; HYPERMETABOLISM; INFLAMMATION; MALE; MULTIVARIATE ANALYSIS; NEPHELOMETRY; OXIDATIVE STRESS; PRECIPITATION; SEX DIFFERENCE; WEIGHT; WEIGHT REDUCTION;

ARGININE; BIOLOGICAL MARKERS; BODY HEIGHT; BODY MASS INDEX; BODY WEIGHT; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DISEASE PROGRESSION; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; KIDNEY FAILURE, CHRONIC; LYSINE; MALE; MIDDLE AGED; NEPHELOMETRY AND TURBIDIMETRY; PROGNOSIS; RENAL DIALYSIS; RISK FACTORS; SEX FACTORS;

EID: 33645473727     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Makita Z, Radoff S, Rayfield EJ, Yang Z, Skolnik E, Delaney V, Friedman EA, Cerami A, Vlassara H. Advanced glycosylation end products in patients with diabetic nephropathy. N Engl J Med 1991; 325: 836-42.
2. Sell DR, Lapolla A, Odetti P, Fogarty J, Monnier V. Pentosidine formation in skin correlates with severity of complications in individuals with long-standing IDDM. Diabetes 1992; 41: 1286-92.
3. Miyata T, van Ypersele de Strihou C, Kurokawa K, Baynes JW. Alterations in nonenzymatic biochemistry in uremia: origin and significance of carbonyl stress in long-term uremic complications. Kidney Int 1999; 55: 389-99.
4. 2-microglobulin modified with advanced glycation end product in the pathogenesis of hemodialysis-associated amyloidosis. J Clin Invest 1994; 93: 521-8.
5. Anglani F, Forino M, Del Prete D, Ceol M, Favaro S. Molecular biology of the peritoneal membrane: in between morphology and function. Contrib Nephrol 2001; 131: 61-73.
6. Mahiout A, Ehlerding G, Brunkhorst R. Advanced glycation end-products in the peritoneal fluid and in the peritoneal membrane of continuous ambulant peritoneal dialysis patients. Nephrol Dial Transplant 1996: 11 (suppl 5): S2-6.
7. Bucala R. Site-specific modification of apolipoprotein B by advanced glycosylation end-products: implications for lipoprotein clearance and atherogenesis. Nephrol Dial Transplant 1996; 11 (suppl 5): S17-9.
8. Bowlee M, Vlassara H, Cerami A. Nonenzymatic glycosylation and the pathogenesis of diabetic complications. Ann Intern Med 1984; 101: 527-37.
9. Makita Z, Yanagisawa K, Kuwajima S, Bucala R, Vlassara H, Koike T. The role of advanced glycosylation end-products in the pathogenesis of atherosclerosis. Nephrol Dial Transplant 1996; 11 (suppl 5): S31-3.
10. Chappey O, Dosquet C, Wautier MP, Wautier JL. Advanced glycation end products, oxidant stress and vascular lesions. Eur J Clin Invest 1997; 27: 97-108.
11. Yan SD, Schmidt AM, Anderson GM, Zhang J, Brett J, Zou JS, Pinsky D, Stern D. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J Biol Chem 1994; 269: 9889-97.
12. Sell D, Monnier V. End-stage renal disease and diabetes catalyze the formation of a pentose-derived crosslink from aging human collagen. J Clin Invest 1990; 85: 380-4.
13. Odetti P, Fogarty J, Sell D, Monnier V. Chromatographic quantitation of plasma and erythrocyte pentosidine in diabetic and uremic subjects. Diabetes 1992; 41: 153-9.
14. Miyata T, Wada Y, Cai Z, Iida Y, Horie K, Yasuda Y, Maeda K, Kurokawa K, van Ypersele de Strihou C. Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure. Kidney Int 1997; 51: 1170-81.
15. Miyata T, Ueda Y, Yamada Y, Izuhara Y, Wada T, Jadoul M, Saito A, Kurokawa K, van Ypersele de Strihou C. Accumulation of carbonyls accelerates the formation of pentosidine, an advanced glycosylation end product: carbonyl stress in uremia. J Am Soc Nephrol 1998; 9: 2349-56.
16. Slowik-Zylka D, Safranow K, Dziedziejko V, Bukowska H, Ciechanowski K, Chlubek D. A sensitive and specific HPLC method for the determination of total pentosidine concentration in plasma. J Biochem Biophys Methods 2004; 61: 313-29.
17. Odetti P, Cosso L, Pronzato MA, Dapino D, Gurreri G. Plasma advanced glycosylation end-products in maintenance haemodialysis patients. Nephrol Dial Transplant 1995; 10: 2110-3.
18. Takahashi M, Kushida K, Kawana K, Ishihara C, Denda M, Inoue T, Horiuchi K. Quantification of the cross-link pentosidine from normal and uremic subjects. Clin Chem 1993; 39: 2162-5.
19. Suliman ME, Heimburger O, Barany P, Anderstam B, Pecoits-Filho R, Ayala ER, Qureshi AR, Fehrman-Ekholm I, Lindholm B, Stenvinkel P. Plasma pentosidine is associated with inflammation and malnutrition in end-stage renal disease patients starting on dialysis therapy. J Am Soc Nephrol 2003; 14: 1614-22.
20. Locatelli F, Fouque D, Heimburger O, Drueke TB, Cannata-Andia JB, Horl WH, Ritz E. Nutritional status in dialysis patients: a European consensus. Nephrol Dial Transplant 2002; 17: 563-72.
21. Gutierrez A. Protein catabolism in maintenance haemodialysis: the influence of the dialysis membrane. Nephrol Dial Transplant 1996; 11 (suppl 2): S108-11.